StemCell Institute (7096) · FactAdvanced
High market share in cord blood and umbilical cord storage services
First written in FY2023. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
High market share in cord blood and umbilical cord storage servicesA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026AdvancedAnnual report
「As of March 2026, 2 private cord blood bank operators, including the Company, had filed the relevant notification. The 2 operators held a total of 95,821 stored cord blood units, of which 95,005 were held by the Company.」
The Company disclosed that it held 95,005 of the 95,821 units stored by the 2 private cord blood banks, providing specific storage figures for its previously reported market share of approximately 99%. - FY2023First statedAnnual report
「During the period, our principal business, the cell banking business, included a cord blood storage service, with a market share of approximately 99%, and Japan's first umbilical cord storage service, launched in April 2021, with a 100% market share.」
The Company reported a market share of approximately 99% for its cord blood storage service and 100% for its umbilical cord storage service, indicating a structurally high market share.